Penumbra (PEN) Reaches $87.07 After 7.00% Up Move; Celanese Del (CE) SI Decreased By 27.49%

June 19, 2017 - By Nellie Frank

Celanese Corporation Del (NYSE:CE) had a decrease of 27.49% in short interest. CE’s SI was 2.49M shares in June as released by FINRA. Its down 27.49% from 3.44M shares previously. With 898,900 avg volume, 3 days are for Celanese Corporation Del (NYSE:CE)’s short sellers to cover CE’s short positions. About 746,297 shares traded. Celanese Corporation (NYSE:CE) has risen 21.48% since June 19, 2016 and is uptrending. It has outperformed by 4.78% the S&P500.

The stock of Penumbra Inc (NYSE:PEN) is a huge mover today! About 53,511 shares traded. Penumbra Inc (NYSE:PEN) has risen 65.49% since June 19, 2016 and is uptrending. It has outperformed by 48.79% the S&P500.The move comes after 9 months positive chart setup for the $2.91B company. It was reported on Jun, 19 by Barchart.com. We have $93.16 PT which if reached, will make NYSE:PEN worth $203.70 million more.

Celanese Corporation is a technology and specialty materials company. The company has market cap of $13.49 billion. The Company’s divisions include Advanced Engineered Materials, Consumer Specialties, Industrial Specialties, Acetyl Intermediates and Other Activities. It has a 16.73 P/E ratio. The Advanced Engineered Materials segment includes the Company’s engineered materials business and certain affiliates.

Among 13 analysts covering Celanese (NYSE:CE), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. Celanese had 35 analyst reports since September 1, 2015 according to SRatingsIntel. The stock of Celanese Corporation (NYSE:CE) earned “Sector Perform” rating by RBC Capital Markets on Monday, November 16. Jefferies maintained it with “Buy” rating and $10400 target in Friday, May 26 report. The rating was maintained by Cowen & Co with “Market Perform” on Monday, October 26. The rating was downgraded by Zacks on Tuesday, September 1 to “Buy”. The firm earned “Buy” rating on Tuesday, January 5 by Citigroup. The stock has “Neutral” rating by Goldman Sachs on Monday, October 12. RBC Capital Markets maintained the shares of CE in report on Wednesday, October 21 with “Sector Perform” rating. The firm has “Overweight” rating given on Wednesday, July 27 by Barclays Capital. Robert W. Baird initiated Celanese Corporation (NYSE:CE) rating on Friday, February 17. Robert W. Baird has “Outperform” rating and $105 target. The company was maintained on Friday, January 22 by UBS.

Investors sentiment increased to 0.95 in Q4 2016. Its up 0.10, from 0.85 in 2016Q3. It improved, as 24 investors sold Celanese Corporation shares while 163 reduced holdings. 77 funds opened positions while 100 raised stakes. 132.47 million shares or 2.18% less from 135.43 million shares in 2016Q3 were reported. Greenwood Capital Associates Ltd Liability Corporation holds 3,605 shares. Icon Advisers Company has invested 0.09% in Celanese Corporation (NYSE:CE). Thrivent Fincl For Lutherans holds 0.06% of its portfolio in Celanese Corporation (NYSE:CE) for 173,638 shares. Laurion Cap Mngmt L P holds 0.01% or 12,300 shares. 1.31M were reported by Retail Bank Of America Corporation De. Gsa Capital Ptnrs Limited Liability Partnership has 0.09% invested in Celanese Corporation (NYSE:CE) for 19,794 shares. Caisse De Depot Et Placement Du Quebec reported 0.01% in Celanese Corporation (NYSE:CE). Tudor Inv Corporation Et Al holds 0.04% of its portfolio in Celanese Corporation (NYSE:CE) for 19,197 shares. Japan-based Sumitomo Mitsui Tru Hldgs Inc has invested 0.06% in Celanese Corporation (NYSE:CE). Jennison holds 0.02% or 250,841 shares in its portfolio. Shell Asset Mgmt, Netherlands-based fund reported 20,465 shares. Synovus accumulated 3,499 shares. C M Bidwell Associate invested in 0.51% or 27,415 shares. Columbia Wanger Asset Management Ltd Limited Liability Company invested in 0.56% or 508,843 shares. 27,762 are owned by Walleye Trading Limited Liability.

Among 5 analysts covering Penumbra (NYSE:PEN), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Penumbra had 8 analyst reports since October 13, 2015 according to SRatingsIntel. The company was initiated on Tuesday, October 13 by Canaccord Genuity. The stock of Penumbra Inc (NYSE:PEN) earned “Buy” rating by BMO Capital Markets on Wednesday, April 12. The company was maintained on Monday, November 30 by Canaccord Genuity. The rating was initiated by JP Morgan with “Overweight” on Tuesday, October 13. BMO Capital Markets maintained Penumbra Inc (NYSE:PEN) on Thursday, May 11 with “Buy” rating. The rating was initiated by Bank of America on Wednesday, October 14 with “Buy”. The stock of Penumbra Inc (NYSE:PEN) has “Outperform” rating given on Tuesday, October 13 by Wells Fargo.

Penumbra, Inc. is a healthcare company focused on interventional therapies. The company has market cap of $2.91 billion. The Firm designs, develops, makes and markets medical devices. It has a 399.02 P/E ratio. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: